[go: up one dir, main page]

GB2188233B - Topical pharmaceutical compositions for treating vitiligo. - Google Patents

Topical pharmaceutical compositions for treating vitiligo.

Info

Publication number
GB2188233B
GB2188233B GB8628373A GB8628373A GB2188233B GB 2188233 B GB2188233 B GB 2188233B GB 8628373 A GB8628373 A GB 8628373A GB 8628373 A GB8628373 A GB 8628373A GB 2188233 B GB2188233 B GB 2188233B
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
topical pharmaceutical
treating vitiligo
vitiligo
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
GB8628373A
Other versions
GB2188233A (en
GB8628373D0 (en
Inventor
Manuel Francisco Belda Galiana
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of GB8628373D0 publication Critical patent/GB8628373D0/en
Publication of GB2188233A publication Critical patent/GB2188233A/en
Application granted granted Critical
Publication of GB2188233B publication Critical patent/GB2188233B/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GB8628373A 1986-03-24 1986-11-27 Topical pharmaceutical compositions for treating vitiligo. Expired - Lifetime GB2188233B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES553334A ES8706027A1 (en) 1986-03-24 1986-03-24 Topical pharmaceutical compositions for treating vitiligo

Publications (3)

Publication Number Publication Date
GB8628373D0 GB8628373D0 (en) 1986-12-31
GB2188233A GB2188233A (en) 1987-09-30
GB2188233B true GB2188233B (en) 1990-07-18

Family

ID=8491041

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8628373A Expired - Lifetime GB2188233B (en) 1986-03-24 1986-11-27 Topical pharmaceutical compositions for treating vitiligo.

Country Status (2)

Country Link
ES (1) ES8706027A1 (en)
GB (1) GB2188233B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4119170C2 (en) * 1991-06-11 2002-04-25 Geb Herber Miltner Remedies for atopic dermatitis
ES2047456B1 (en) * 1992-07-31 1994-10-01 Herrando Carlos Postigo COMPOSITION TO OBTAIN A COSMETIC PRODUCT AND SIMILAR PRODUCTS.
CN1042896C (en) * 1993-12-06 1999-04-14 广东医学院 External compound corticoid preparation
FR2718022B1 (en) * 1994-04-01 1996-04-26 Roussel Uclaf Cosmetic or dermatological compositions and their preparation.
ES2083333B1 (en) * 1994-09-22 1997-01-16 Corral Begona Gozalo CREAM FOR THE TREATMENT OF PSORIASIS.
ES2119726B1 (en) * 1997-03-20 1999-04-01 Reolid Manuel Sanchez COMPOSITION OF A PRODUCT FOR BODY APPLICATION.
ES2156765B1 (en) * 1999-11-05 2002-02-01 Herrando Carlos Postigo COMPOSITION OF A PRODUCT APPLICABLE TO SKIN.
KR100798853B1 (en) * 2005-02-15 2008-01-28 (주)한국스티펠 Pharmaceutical composition for the prevention and treatment of vitiligo with retinoids as an active ingredient
ES2607630B2 (en) * 2016-03-09 2017-09-25 Paz LOPEZ PITA Topical cream of clobetasol-17 propionate, urea and marigold oil and manufacturing procedure

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
Lanolin, p10 *
Martindale, *
The Merck Ma *
Tretinoin (R *
Triamcinolon *
Urea, pp616- *

Also Published As

Publication number Publication date
GB2188233A (en) 1987-09-30
ES8706027A1 (en) 1987-05-16
GB8628373D0 (en) 1986-12-31
ES553334A0 (en) 1987-05-16

Similar Documents

Publication Publication Date Title
EP0243145A3 (en) Topical antimicrobial pharmaceutical compositions
GB2155337B (en) Topical delivery system for skin treatment compositions
AU7061687A (en) Pharmaceutical composition for treating periodontal diseases
GB2196964B (en) Pharmaceutical compositions
PH25150A (en) Novel pharmaceutical preparation for topical application
GB8613688D0 (en) Pharmaceutical composition
GB8708659D0 (en) Pharmaceutical composition
EP0249397A3 (en) Improved penetrating topical pharmaceutical compositions
GB2191696B (en) Pharmaceutical compositions
GB2190838B (en) Pharmaceutical compositions
GB2188233B (en) Topical pharmaceutical compositions for treating vitiligo.
GB8713632D0 (en) Oculistics pharmaceutical composition
GB2163051B (en) Drug composition for the treating or preventing acne by topical application
GB2188235B (en) Pharmaceutical compositions
GB2167958B (en) Compositions for treating the scalp.
GB8709166D0 (en) Pharmaceutical composition
GB2194439B (en) Topical pharmaceutical compositions containing iodophor
GB8614189D0 (en) Pharmaceutical composition
GB8706824D0 (en) Pharmaceutical composition
GB8722205D0 (en) Pharmaceutical composition
IE862553L (en) Pharmaceutical compositions for treatment gastrointestinal¹disorders
GB8725539D0 (en) Pharmaceutical composition
ZA876748B (en) Pharmaceutical composition
GB8704660D0 (en) Pharmaceutical composition
ZA876263B (en) Pharmaceutical composition

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19951127